VanEck Pharmaceutical ETF
43 hedge funds and large institutions have $129M invested in VanEck Pharmaceutical ETF in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2% more call options, than puts
Call options by funds: $819K | Put options by funds: $802K
0% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 12
Holders
43
Holding in Top 10
–
Calls
$819K
Puts
$802K
Top Buyers
| 1 | +$41.1M | |
| 2 | +$22.8M | |
| 3 | +$11.4M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$8.53M |
| 5 |
JP Morgan Chase
New York
|
+$5.69M |
Top Sellers
| 1 | -$8.37M | |
| 2 | -$2.3M | |
| 3 | -$2.23M | |
| 4 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
-$798K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$722K |